An International Observational Registry Study to Further Describe Long-term Safety and Effectiveness of Palovarotene in Patients with Fibrodysplasia Ossificans Progressiva (FOP) (FOPal)

02/04/2024
06/10/2025
EU PAS number:
EUPAS1000000060
Study
Ongoing
Documents
Study protocol
Initial protocol
English (6.31 MB - PDF) View document
Updated protocol
English (8.49 MB - PDF) View document
Study results
Study report
Other information